Literature DB >> 31456912

Immunohistochemical features of carcinoma ex pleomorphic adenoma and pleomorphic adenoma in the lacrimal gland.

Ping Zhang1, Li-Juan Tang1, Huan-Huan Gao1, Wen-Xin Zhang1, Jian-Xian Lin1, Hua-Sheng Yang2.   

Abstract

AIM: To investigate C-myc, Ki-67, pan-cytokeratin, and vimentin immunohistochemical features of carcinoma ex pleomorphic adenoma (Ca-ex-PA) and pleomorphic adenoma (PA) in the lacrimal gland in order to find some clues in the differential diagnosis between them.
METHODS: We reviewed microscopic slides and clinical records of 64 cases of PA and 15 cases of Ca-ex-PA in the lacrimal gland. Immunohistochemical antibodies for C-myc, Ki-67, pan-cytokeratin, and vimentin were employed.
RESULTS: Median age of PA was 43.2y (from 21 to 75). The 35 patients (54.7%) were male and 29 patients (45.3%) were female. For the PAs, the average positivity of C-myc was 4.6%; the average proliferation index of Ki-67 was 3.2%; pan-cytokeratin was positive in ductal cells, and vimentin was positive in myoepithelial cells. Median age of Ca-ex-PA was 54.3y (from 26 to 76). There were 7 male patients (46.7%) and 8 female patients (53.3%). Among 15 Ca-ex-PAs, there were 6 myoepithelial carcinomas, 4 adenocarcinomas, 3 epithelial-myoepithelial carcinomas, and 2 squamous cell carcinomas. For the Ca-ex-PAs, the average positivity of C-myc was 36.4%; the average proliferation index of Ki-67 was 29.2%; pan-cytokeratin was positive in all cases, and vimentin was positive in myoepithelial carcinomas.
CONCLUSION: PA has a lower positivity of C-myc and Ki-67, while Ca-ex-PA had a higher positivity of these two biomarkers. These four biomarkers as a set could provide valuable clues in the differential diagnosis between Ca-ex-PA and PA. Our results indicate that the activation of C-myc could play an important role in the pathogenesis of Ca-ex-PA and PA.

Entities:  

Keywords:  C-myc; carcinoma ex pleomorphic adenoma; immunohistochemistry; pleomorphic adenoma

Year:  2019        PMID: 31456912      PMCID: PMC6694048          DOI: 10.18240/ijo.2019.08.02

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  4 in total

1.  Clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma.

Authors:  Rui Liu; Nan Wang; Hong Zhang; Xin Ge; Jian-Min Ma
Journal:  Int J Ophthalmol       Date:  2021-12-18       Impact factor: 1.779

2.  Retrospective Analysis of Clinicopathological Characteristics of Lacrimal Gland Pleomorphic Adenoma and Mechanism of Tumorigenesis by the Imbalance Between Apoptosis and Proliferation.

Authors:  Meng Lv; Zhi-Jun Dong; Yue-Xin Tong; Tian Li; Yan Hei; Xin-Ji Yang; Wei-Li Dong
Journal:  Med Sci Monit       Date:  2021-03-19

3.  Proptosis Revealing a Rare Lacrimal Gland Tumor: A Case of Chondroid Syringoma in a 35-year-old Patient.

Authors:  Boubacar Efared; Kadre Ousmane Kadre Alio; Boubacar Idrissa; Aïchatou Balaraba Abani Bako; Habiba Salifou Boureima; Ali Salèye; Nouhou Hassan
Journal:  Clin Pathol       Date:  2022-01-09

4.  Ductal Adenocarcinoma Ex Pleomorphic Adenoma of the Lacrimal Gland: a Rare and Morbid Malignancy.

Authors:  Prashanth Ashok Kumar; Shweta Paulraj; Kanish Mirchia; Seung Shin Hahn; Abirami Sivapiragasam
Journal:  Case Rep Oncol Med       Date:  2020-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.